Welcome to our dedicated page for Option Care Health SEC filings (Ticker: OPCH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Option Care Health, Inc. filings document the public-company disclosures of a Nasdaq-listed provider of home and alternate-site infusion services. Its common stock is registered under the symbol OPCH, and its regulatory record includes Current Reports on Form 8-K, proxy materials, and exhibits tied to operating results and corporate actions.
OPCH filings cover quarterly and annual financial results, non-GAAP measure reconciliations, Regulation FD investor presentations, amendments to its first lien credit agreement, executive officer changes and related severance matters, and definitive proxy disclosures. The proxy record addresses board governance, stockholder voting matters, executive compensation, and capital allocation context for the company's infusion services business.
Bierbower Elizabeth D reported acquisition or exercise transactions in this Form 4 filing.
Option Care Health director Elizabeth D. Bierbower received an equity grant. She was awarded 8,997 shares of common stock as restricted stock units valued at $200,000, based on the closing price on May 20, 2026. These units vest in full on May 20, 2027, bringing her direct holdings to 32,871 shares.
Deckmann Natasha reported acquisition or exercise transactions in this Form 4 filing.
Option Care Health, Inc. director Natasha Deckmann reported two equity awards of common stock on May 20, 2026. She received 8,997 restricted stock units that vest in full on May 20, 2027, granted in lieu of cash retainer payments. She also received an additional award of 844 restricted stock units, calculated to reflect $200,000 of value based on the closing share price on the grant date, which will also vest fully on May 20, 2027.
KRAEMER HARRY M JANSEN JR reported acquisition or exercise transactions in this Form 4 filing.
Option Care Health director Harry M. Jansen Kraemer Jr. reported two stock-based compensation awards on common stock. He received 12,079 restricted stock units valued using a $200,000 target amount based on the May 20, 2026 closing price, plus 8,997 restricted stock units granted in lieu of cash retainer fees. Both awards vest in full on May 20, 2027 and represent equity compensation grants, not open-market purchases.
Pate R Carter reported acquisition or exercise transactions in this Form 4 filing.
Option Care Health, Inc. director Pate R. Carter reported receiving an equity grant in the form of restricted stock units. The award covers 8,997 shares of common stock at a stated price of $0.00 per share and brings direct holdings to 20,620 shares after the transaction. A footnote explains the restricted stock units were valued at $200,000 based on the closing price on May 20, 2026, and they vest in full on May 20, 2027.
Option Care Health director Timothy P. Sullivan reported two stock awards from the company. On May 20, 2026 he acquired 4,836 shares of common stock at a reference price of $22.23 per share as a restricted stock unit award reflecting $200,000 of value. He also received 8,997 restricted stock units in lieu of cash retainer fees, with both grants based on the same closing share price. All these restricted stock units vest in full on May 20, 2027, representing routine equity-based director compensation rather than open-market share purchases.
Option Care Health director Barbara W. Bodem received an equity award of 8,997 common shares on May 20, 2026. The award represents restricted stock units valued at $200,000 based on the issuer’s closing share price on that date and carries no cash exercise cost.
The restricted stock units vest in full on May 20, 2027, meaning Bodem must remain in service through that date to receive the underlying shares. Following this grant, she beneficially owns 21,087 common shares directly, according to the filing.
Wright Norman L. reported acquisition or exercise transactions in this Form 4 filing.
Option Care Health, Inc. director Norman L. Wright reported an equity award rather than a market trade. On May 20, 2026, he received 8,997 restricted stock units, designed to reflect $200,000 of value based on that day’s closing share price. These units vest in full on May 20, 2027, meaning he must remain eligible through that date to receive all shares. Following this award, Wright directly holds 24,498 shares of the company’s common stock.
Option Care Health director Eric Brandt reported equity awards of common stock as part of his compensation. On May 20, 2026 he acquired 2,643 shares of common stock at an indicated value of $22.23 per share through a grant classified as a “grant, award, or other acquisition.”
On the same date, he also received 8,997 restricted stock units in lieu of cash retainer payments, recorded at a price of $0.00 per share. Footnotes state one award was sized to represent $200,000 of value and that both RSU awards vest in full on May 20, 2027. Following these awards, Brandt directly holds 21,999 shares of Option Care Health common stock.
Option Care Health, Inc. reported results from its 2026 Annual Meeting of Stockholders held on May 20, 2026. Stockholders elected nine director nominees, each receiving over 143 million votes in favor, with additional broker non-votes recorded on each item.
Stockholders also ratified KPMG LLP as independent registered public accounting firm for the year ending December 31, 2026, with 149,076,945 votes for and 1,132,306 against. In a separate non-binding advisory vote, stockholders approved the company’s executive officer compensation, with 141,106,639 votes for and 4,192,721 against.
Option Care Health executive Collin Smyser reported routine equity compensation activity. On May 19, 2026, he exercised 812 Restricted Stock Units, converting them into the same number of common shares. In connection with this, 360 common shares were disposed of to satisfy tax obligations.
After these transactions, Smyser directly owned 75,372 common shares and indirectly held 2,500 common shares through a revocable trust. No open-market purchases or sales were reported, indicating these movements reflect compensation vesting and related tax withholding rather than discretionary trading.